Zymeworks (ZYME) FCF Margin (2021 - 2026)
Zymeworks' (ZYME) quarterly FCF Margin came in at 1902.74% in Q1 2026, down 179232.0% year-on-year from N/an in Q1 2025, and down 413.51% quarter-over-quarter from 370.54% in Q4 2025.
Zymeworks (ZYME) FCF Margin (2021 - 2026) Analysis & Trends
Zymeworks has disclosed FCF Margin across 6 years of filings, most recently posting 1902.74% for Q1 2026.
- FCF Margin for Q1 2026 came in at 1902.74%, down 179232.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 95.87% (up 3454.0% YoY), and the FY2025 annual result was 31.15%, up 11309.0% from the prior year.
- FCF Margin came in at 1902.74% for Q1 2026 at Zymeworks, down from 370.54% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 98.66% in Q4 2022 to a low of 3109.08% in Q1 2022.
- The 5-year median for FCF Margin is 234.91% (2023), against an average of 625.22%.
- Across the five-year window, FCF Margin jumped 287417 bps in 2023 and sank 179232 bps in 2026, its largest moves.
- Zymeworks' FCF Margin stood at 98.66% in 2022, then decreased by 19 bps to 80.21% in 2023, then slumped by 260 bps to 128.37% in 2024, then sank by 189 bps to 370.54% in 2025, then tumbled by 414 bps to 1902.74% in 2026.
- The last three FCF Margin figures came in at 1902.74% (Q1 2026), 370.54% (Q4 2025), and 127.29% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Zymeworks | 1.71 Bn | 1.35 Bn | - | -1,902.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,902.74% |
| Dec 31, 2025 | -370.54% |
| Sep 30, 2025 | -127.29% |
| Jun 30, 2025 | 23.72% |
| Mar 31, 2025 | -110.42% |
| Dec 31, 2024 | -128.37% |
| Sep 30, 2024 | -42.37% |
| Jun 30, 2024 | -322.14% |
| Mar 31, 2024 | -375.62% |
| Dec 31, 2023 | 80.21% |
| Sep 30, 2023 | -264.13% |
| Jun 30, 2023 | -102.84% |
| Mar 31, 2023 | -234.91% |
| Dec 31, 2022 | 98.66% |
| Sep 30, 2022 | -2,791.45% |
| Jun 30, 2022 | -949.45% |
| Mar 31, 2022 | -3,109.08% |
| Dec 31, 2021 | -691.15% |